Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2009 1
2010 3
2011 4
2012 1
2014 2
2015 2
2016 2
2017 3
2018 5
2019 3
2020 2
2021 5
2022 2
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Atypical hemolytic uremic syndrome with complement gene abnormality"
Page 1
Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
Raina R, Krishnappa V, Blaha T, Kann T, Hein W, Burke L, Bagga A. Raina R, et al. Ther Apher Dial. 2019 Feb;23(1):4-21. doi: 10.1111/1744-9987.12763. Epub 2018 Oct 29. Ther Apher Dial. 2019. PMID: 30294946 Review.
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal impairment. ...Abnormalities of the complement pathway may …
Atypical hemolytic uremic syndrome (aHUS), a rare variant of thrombotic microangiopathy, is characterized by mic …
Inherited Kidney Complement Diseases.
Lemaire M, Noone D, Lapeyraque AL, Licht C, Frémeaux-Bacchi V. Lemaire M, et al. Clin J Am Soc Nephrol. 2021 Jun;16(6):942-956. doi: 10.2215/CJN.11830720. Epub 2021 Feb 3. Clin J Am Soc Nephrol. 2021. PMID: 33536243 Free PMC article. Review.
In the past 20 years, we have witnessed tremendous advances in our ability to diagnose and treat genetic diseases of the kidney caused by complement dysregulation. Staggering progress was realized toward a better understanding of the genetic underpinnings and pathophysiolo …
In the past 20 years, we have witnessed tremendous advances in our ability to diagnose and treat genetic diseases of the kidney caused by …
Atypical hemolytic uremic syndrome.
Loirat C, Frémeaux-Bacchi V. Loirat C, et al. Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Orphanet J Rare Dis. 2011. PMID: 21902819 Free PMC article. Review.
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. ...The incidence of complement-aHUS is not known precisely. However, more than 1000 aHUS patients investigated for …
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and ren …
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological Features.
Chabannes M, Rabant M, El Sissy C, Dragon-Durey MA, Vieira Martins P, Meuleman MS, Karras A, Buob D, Bridoux F, Daugas E, Audard V, Caillard S, Olagne J, Kandel C, Ferlicot S, Philipponnet C, Crepin T, Thervet E, Ducloux D, Frémeaux-Bacchi V, Chauvet S. Chabannes M, et al. Am J Kidney Dis. 2023 Sep;82(3):279-289. doi: 10.1053/j.ajkd.2022.12.020. Epub 2023 Apr 14. Am J Kidney Dis. 2023. PMID: 37061020
RATIONALE & OBJECTIVE: C3 glomerulopathy (C3GN) and atypical hemolytic uremic syndrome (aHUS) are 2 distinct rare kidney diseases caused by dysregulation of the alternative complement pathway. ...Fifty percent of the patients had low C3 leve …
RATIONALE & OBJECTIVE: C3 glomerulopathy (C3GN) and atypical hemolytic uremic syndrome (aHUS) are 2 distinct …
Genetics and CKD.
Vehaskari VM. Vehaskari VM. Adv Chronic Kidney Dis. 2011 Sep;18(5):317-23. doi: 10.1053/j.ackd.2011.07.001. Adv Chronic Kidney Dis. 2011. PMID: 21896372 Review.
Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously unknown genes and pathogenetic pathways. Mutations affecting the integrity of the glomerular filtration barrier cause proteinuria or nephr …
Molecular biology methods have clarified the underlying mutations in several types of CKD, and in the process have revealed previously unkno …
Diagnosis of complement alternative pathway disorders.
Angioi A, Fervenza FC, Sethi S, Zhang Y, Smith RJ, Murray D, Van Praet J, Pani A, De Vriese AS. Angioi A, et al. Kidney Int. 2016 Feb;89(2):278-88. doi: 10.1016/j.kint.2015.12.003. Kidney Int. 2016. PMID: 26806831 Free article. Review.
Kidney diseases resulting from abnormal control of the complement alternative pathway include atypical hemolytic uremic syndrome, C3 glomerulonephritis, and dense-deposit disease, as well as atypical postinfectious glomerulonephrit …
Kidney diseases resulting from abnormal control of the complement alternative pathway include atypical hemolytic …
De novo thrombotic microangiopathy after kidney transplantation.
Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K. Garg N, et al. Transplant Rev (Orlando). 2018 Jan;32(1):58-68. doi: 10.1016/j.trre.2017.10.001. Epub 2017 Nov 4. Transplant Rev (Orlando). 2018. PMID: 29157988 Review.
Post-transplant TMA is usually classified into two categories: 1) recurrent TMA and 2) de novo TMA. Atypical hemolytic uremic syndrome (aHUS) resulting from dysregulation and over-activation of the alternate complement pathway is a rare disease …
Post-transplant TMA is usually classified into two categories: 1) recurrent TMA and 2) de novo TMA. Atypical hemolytic urem …
Kidney Transplant Outcomes in Patients with Atypical Hemolytic Uremic Syndrome.
Balwani MR, Pasari AS, Gurjar P, Bhawane A, Bawankule C, Tolani P, Kashiv P, Dubey S, Katekhaye VM. Balwani MR, et al. Transplant Proc. 2023 Jun;55(5):1312-1315. doi: 10.1016/j.transproceed.2023.02.066. Epub 2023 May 16. Transplant Proc. 2023. PMID: 37202305
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare disorder with a high probability of recurrence after a kidney transplant and can adversely affect the graft outcome. ...RESULTS: Among 47 patients with AFH antibody levels >100 AU/mL, 5 …
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare disorder with a high probability of recurrence a …
Genetics of hemolytic uremic syndromes.
Malina M, Roumenina LT, Seeman T, Le Quintrec M, Dragon-Durey MA, Schaefer F, Fremeaux-Bacchi V. Malina M, et al. Presse Med. 2012 Mar;41(3 Pt 2):e105-14. doi: 10.1016/j.lpm.2011.10.028. Epub 2012 Jan 20. Presse Med. 2012. PMID: 22265161 Review.
Atypical HUS appears to have a genetic basis. Mutations in genes coding for components of the alternative complement pathway are found in about 60% of cases. ...The pathophysiology of the disease and the implication of genetic abnormalities in the c …
Atypical HUS appears to have a genetic basis. Mutations in genes coding for components of the alternative complement pa …
Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab.
Verhave JC, Wetzels JF, van de Kar NC. Verhave JC, et al. Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv131-41. doi: 10.1093/ndt/gfu235. Nephrol Dial Transplant. 2014. PMID: 25165180 Review.
The most common etiologies of HUS are the ones seen in childhood caused by an infection of Shiga toxin-producing Escherichia coli, HUS caused by an infection with Streptococcus pneumoniae and HUS due to abnormalities in the alternative pathway of the complement s …
The most common etiologies of HUS are the ones seen in childhood caused by an infection of Shiga toxin-producing Escherichia coli, HUS cause …
37 results